NTHI Stock Analysis: Buy, Sell, or Hold?

NTHI - NeOnc Technologies Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$9.27
0.52 (5.94%) ▲
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 13, 2026 12d

Get Alerted When NTHI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: NTHI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.

In-depth Analysis How we analyze

Valuation Analysis: NTHI is currently trading at $9.27, which is considered slightly high relative to its 30-day fair value range of $8.32 to $9.45.

Technical Outlook: Technically, NTHI is in a downtrend. Immediate support is located at $7.99, while resistance sits at $10.26. The stock is showing strong short-term momentum, up 5.9% recently.

Market Sentiment: NTHI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $8.32 - $9.45
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.4%

All Signals

  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+5.9%)

Fair Price Analysis

30-Day Fair Range $8.32 - $9.45
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $7.99
Resistance Level $10.26
Current Trend Downtrend

Fundamental Context

Revenue Growth (YoY) -7.0%
Last updated: January 30, 2026 7:42 PM ET
Data refreshes hourly during market hours. Next update: 8:42 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$22 60 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1035 58 HOLD
CRSP
Crispr Therapeutics AG
BUY
28 analysts
$83 57 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$33 60 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD

Advanced NTHI Option Strategies

Professional options setups generated by AI based on today's NTHI price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NTHI

NTHI Technical Chart NTHI Price Prediction NTHI Earnings Date NTHI Investment Advisor NTHI Fair Price Analyzer NTHI Options Advisor NTHI Options Chain NTHI Options Analysis NTHI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals